Betavert Tablet

Betahistine Dihydrochloride

24 mg

Jamjoom Pharmaceuticals Company Ltd.

Pack size	30's Pack
Dispensing mode
Source
Agent
Retail Price	0.81 AED

Available as:

8 mg - Tablet 16 mg - Tablet

Indications

Betavert Tablet is used for: Meniere's disease, tinnitus and/or progressive loss of hearing, vertigo, dizziness.

Adult Dose

Adult: Initially, 8-16 mg tid. Maintenance: 24-48 mg daily.

Child Dose

Renal Dose

Administration

Should be taken with food.

Contra Indications

Phaeochromocytoma. Porphyria.

Precautions

Active peptic ulcer, bronchial asthma, pregnancy and lactation.

Pregnancy-Lactation

Interactions

May antagonise antihistamines. May decrease bronchodilator effects of beta-2 agonists.

Adverse Effects

Side effects of Betahistine Dihydrochloride : Rash, pruritus, urticaria, dyspepsia, nausea, peptic ulcer disease, headache, dizziness, insomnia.

Mechanism of Action

Betahistine improves the microcirculation in the labyrinth which reduces endolymphatic pressure.

Note

Betavert 24 mg Tablet manufactured by Jamjoom Pharmaceuticals Company Ltd.. Its generic name is Betahistine Dihydrochloride. Betavert is availble in Saudi Arabia. Farmaco SA drug index information on Betavert Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Betahistine Dihydrochloride :

Tablet

BERTIGO ^{8 mg}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Tablet

BERTIGO ^{24 mg}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

Tablet

BERTIGO ^{16 mg}

ACINO MEA FZ-LLC MIDDLE EAST AFRICA SCIENTFIC OFFICE

BAXTER HEALTHCARE CORPORATION